Effects of Botulinum Toxin on Reducing the Co-contraction of Antagonists in Birth Brachial Plexus Palsy.
10.5535/arm.2014.38.1.127
- Author:
Yong Beom SHIN
1
;
Myung Jun SHIN
;
Jae Hyeok CHANG
;
Young Sun CHA
;
Hyun Yoon KO
Author Information
1. Department of Rehabilitation Medicine, Pusan National University School of Medicine, Busan, Korea. drshinmj@gmail.com
- Publication Type:Case Report
- Keywords:
Birth brachial plexus palsy;
Obstetric brachial plexus injury;
Botulinum toxin type A;
Brachial plexus neuropathies
- MeSH:
Botulinum Toxins*;
Botulinum Toxins, Type A;
Brachial Plexus Neuropathies;
Brachial Plexus*;
Congenital Abnormalities;
Contracture;
Elbow;
Joints;
Muscles;
Occupational Therapy;
Paralysis*;
Parturition*;
Shoulder;
Traction
- From:Annals of Rehabilitation Medicine
2014;38(1):127-131
- CountryRepublic of Korea
- Language:English
-
Abstract:
Birth brachial plexus palsy (BBPP) is usually caused by plexus traction during difficult delivery. Although the possibility of complete recovery is relatively high, 5% to 25% of BBPP cases result in prolonged and persistent disability. In particular, muscle imbalance and co-contraction around the shoulder and elbow cause abnormal motor performance, osseous deformities, and joint contracture. Physical and occupational therapies have most commonly been used, but these conventional therapeutic strategies have often been inadequate, in managing the residual muscle imbalance and muscle co-contraction. Therefore, we attempted to improve the functional movements, by using botulinum toxin type A, to reduce the abnormal co-contraction of the antagonist muscles.
